Nice find. When I look at the possibilities ahead, I am getting more and more convinced we should go it alone for Phase 3 and subsequently license the drug. At close to $1B MC, we can afford to raise for a $200M trial. It appears we have some strong support from a few funds who continue to buy up at these levels and would happily open up the purse strings for a potential 5-Disallowed from here.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| OPT (ASX) Chart |
Day chart unavailable